Literature DB >> 26280511

[Tumor-associated macrophages: Function and differentiation].

G Niedobitek1, M H Barros, J H Dreyer, F Hauck, D Al-Sheikhyaqoob.   

Abstract

Macrophages are important factors in the pathogenesis and prognosis of malignant tumors and represent a possible target for therapeutic intervention. Depending on the tumor entity and the prevalent polarization status, macrophages can be associated with a favorable or unfavorable clinical outcome. It is becoming clear, however, that the conventional definitions of M1 polarized tumor inhibitory and M2 polarized tumor promoting macrophages do not adequately reflect the heterogeneity and plasticity of macrophages. Macrophages can support tumor growth through direct interactions with the neoplastic cells, by promoting tissue remodeling and angiogenesis and by inhibiting local immune reactions. To achieve comparability of clinical studies, it will be necessary to reach a consensus nomenclature of macrophage polarization. Furthermore, methods for the quantitative characterization of macrophage populations in malignant tumors will have to be standardized. It is unlikely that single marker immunohistochemistry will be adequate in this context. In any case it is necessary to provide unequivocal information regarding the markers or marker combinations used.

Entities:  

Mesh:

Year:  2015        PMID: 26280511     DOI: 10.1007/s00292-015-0054-7

Source DB:  PubMed          Journal:  Pathologe        ISSN: 0172-8113            Impact factor:   1.011


  60 in total

1.  Metchnikoff and the phagocytosis theory.

Authors:  Alfred I Tauber
Journal:  Nat Rev Mol Cell Biol       Date:  2003-11       Impact factor: 94.444

Review 2.  Macrophage plasticity and polarization: in vivo veritas.

Authors:  Antonio Sica; Alberto Mantovani
Journal:  J Clin Invest       Date:  2012-03-01       Impact factor: 14.808

3.  Clinical quantitation of immune signature in follicular lymphoma by RT-PCR-based gene expression profiling.

Authors:  Richard J Byers; Ebrahim Sakhinia; Preethi Joseph; Caroline Glennie; Judith A Hoyland; Lia P Menasce; John A Radford; Timothy Illidge
Journal:  Blood       Date:  2008-01-03       Impact factor: 22.113

Review 4.  Neutralizing tumor-promoting chronic inflammation: a magic bullet?

Authors:  Lisa M Coussens; Laurence Zitvogel; A Karolina Palucka
Journal:  Science       Date:  2013-01-18       Impact factor: 47.728

5.  PG-M1: a new monoclonal antibody directed against a fixative-resistant epitope on the macrophage-restricted form of the CD68 molecule.

Authors:  B Falini; L Flenghi; S Pileri; M Gambacorta; B Bigerna; H Durkop; F Eitelbach; J Thiele; R Pacini; A Cavaliere
Journal:  Am J Pathol       Date:  1993-05       Impact factor: 4.307

6.  Macrophages: Good guys in colorectal cancer.

Authors:  Sofia Edin; Maria L Wikberg; Per-Arne Oldenborg; Richard Palmqvist
Journal:  Oncoimmunology       Date:  2013-02-01       Impact factor: 8.110

7.  M2-polarized tumor-associated macrophages promoted epithelial-mesenchymal transition in pancreatic cancer cells, partially through TLR4/IL-10 signaling pathway.

Authors:  Chao-Ying Liu; Juan-Ying Xu; Xiao-Yan Shi; Wei Huang; Ting-Yan Ruan; Ping Xie; Jun-Li Ding
Journal:  Lab Invest       Date:  2013-06-10       Impact factor: 5.662

8.  Prognostic significance of tumor-associated macrophages in solid tumor: a meta-analysis of the literature.

Authors:  Qiong-wen Zhang; Lei Liu; Chang-yang Gong; Hua-shan Shi; Yun-hui Zeng; Xiao-ze Wang; Yu-wei Zhao; Yu-quan Wei
Journal:  PLoS One       Date:  2012-12-28       Impact factor: 3.240

Review 9.  The M1 and M2 paradigm of macrophage activation: time for reassessment.

Authors:  Fernando O Martinez; Siamon Gordon
Journal:  F1000Prime Rep       Date:  2014-03-03

10.  The role of macrophages polarization in predicting prognosis of radically resected gastric cancer patients.

Authors:  Francesco Pantano; Pierpaolo Berti; Francesco Maria Guida; Giuseppe Perrone; Bruno Vincenzi; Michelina Maria Carla Amato; Daniela Righi; Emanuela Dell'aquila; Francesco Graziano; Vincenzo Catalano; Marco Caricato; Sergio Rizzo; Andrea Onetti Muda; Antonio Russo; Giuseppe Tonini; Daniele Santini
Journal:  J Cell Mol Med       Date:  2013-11-27       Impact factor: 5.310

View more
  2 in total

1.  PD-L1 induced by IFN-γ from tumor-associated macrophages via the JAK/STAT3 and PI3K/AKT signaling pathways promoted progression of lung cancer.

Authors:  Xiaohui Zhang; Yuanyuan Zeng; Qiuxia Qu; Jianjie Zhu; Zeyi Liu; Weiwei Ning; Hui Zeng; Nan Zhang; Wenwen Du; Cheng Chen; Jian-An Huang
Journal:  Int J Clin Oncol       Date:  2017-07-26       Impact factor: 3.402

2.  M2-polarized tumor-associated macrophages facilitated migration and epithelial-mesenchymal transition of HCC cells via the TLR4/STAT3 signaling pathway.

Authors:  Rong-Rong Yao; Jing-Huan Li; Rui Zhang; Rong-Xin Chen; Yan-Hong Wang
Journal:  World J Surg Oncol       Date:  2018-01-16       Impact factor: 2.754

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.